ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL Test
Welcome to DNA Labs UAE, where we offer the ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL test. This diagnostic test utilizes next-generation sequencing (NGS) technology to identify genetic mutations in genes associated with JMML, a rare type of childhood leukemia.
Test Components
The ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL test includes the following components:
- ASXL1
- CBL
- DNMT3A
- EZH2
- GATA2
- KRAS
- NF1
- NRAS
- PTPN 11
- RUNX1
- SETBP1
- SH2B3
- ZRSR2
Price
The cost of the ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL test is 8190.0 AED.
Sample Condition
The sample condition required for this test is 3 mL (2 mL min.) of whole blood or bone marrow in 1 Lavender top (EDTA) tube. The sample should be shipped refrigerated and must not be frozen. Additionally, a duly filled NGS Test Requisition Form is mandatory.
Report Delivery
The sample for the ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL test should be submitted by the 1st or 16th of every month, and the report will be delivered on the 15th or 30th of the same month.
Method
The ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL test utilizes next-generation sequencing (NGS) technology.
Test Type
This test is specifically designed for the diagnosis of leukemia, particularly Juvenile Myelomonocytic Leukemia (JMML).
Doctor
The ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL test is recommended for hematologists and oncologists.
Test Department
This test is conducted in the Molecular Diagnostics department of DNA Labs UAE.
Pre Test Information
A duly filled NGS Test Requisition Form is mandatory before undergoing the ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL test.
Test Details
The Oncomine Juvenile Myelomonocytic Leukemia (JMML) Panel is a diagnostic test that uses next-generation sequencing (NGS) technology to identify genetic mutations in genes associated with JMML, a rare type of childhood leukemia. The panel includes 29 genes that have been found to be mutated in JMML patients, including genes involved in the RAS signaling pathway, which is often dysregulated in JMML. The test can help clinicians diagnose JMML and guide treatment decisions, as well as provide valuable information for researchers studying the disease. The Oncomine JMML Panel is available through Thermo Fisher Scientific’s Oncomine portfolio of cancer research assays.
Test Name | ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA JMML PANEL Test |
---|---|
Components | ASXL1, CBL, DNMT3A, EZH2, GATA2, KRAS, NF1, NRAS, PTPN 11, RUNX1, SETBP1,SH2B3, ZRSR2 |
Price | 8190.0 AED |
Sample Condition | 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Formis mandatory. |
Report Delivery | Sample by 1st / 16th of every month; Report 15th / 30th of Same month |
Method | NGS |
Test type | Leukemia |
Doctor | Hematologist, Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
Test Details |
The Oncomine Juvenile Myelomonocytic Leukemia (JMML) Panel is a diagnostic test that uses next-generation sequencing (NGS) technology to identify genetic mutations in genes associated with JMML, a rare type of childhood leukemia. The panel includes 29 genes that have been found to be mutated in JMML patients, including genes involved in the RAS signaling pathway, which is often dysregulated in JMML. The test can help clinicians diagnose JMML and guide treatment decisions, as well as provide valuable information for researchers studying the disease. The Oncomine JMML Panel is available through Thermo Fisher Scientific’s Oncomine portfolio of cancer research assays. |